Canada-based laboratory software company GenoLogics secured $8m of series D funding on Thursday in a round led by biotechnology analysis firm Illumina.
GenoLogics raised $5m in series C financing, in February 2009, from venture capital firm OVP Venture Partners, Yaletown Venture Partners and Growthworks Capital, all of which also invested in GenoLogics’ 2006 series B round. OVP originally provided $3.1m in series A financing in February 2005.
The funding follows Genologics’ signing of a global co-selling agreement with Illumina in February to market a version of Genologics’ laboratory information managent system pre-configured for Illumina’s instruments and sample preparation kits.
Tristan Orpin, senior vice-president at Illumina, said: "This strategic investment in GenoLogics will benefit our mutual sequencing customers. We value the unique data management capabilities GenoLogics brings to our customers and the industry."